News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,020 Results
Type
Article (13596)
Company Profile (40)
Press Release (229379)
Multimedia
Podcasts (98)
Webinars (14)
Section
Business (80920)
Career Advice (668)
Deals (15272)
Drug Delivery (127)
Drug Development (31851)
Employer Resources (58)
FDA (8123)
Job Trends (5716)
News (124836)
Policy (11617)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (8)
2027 BioCapital Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (498)
Accelerated approval (31)
ADA (23)
Adcomms (21)
Allergies (100)
Alliances (15742)
ALS (116)
Alzheimer's disease (860)
Antibody-drug conjugate (ADC) (298)
Approvals (8519)
Artificial intelligence (420)
ASCO (146)
Autoimmune disease (224)
Automation (19)
Bankruptcy (155)
Belgium (12)
Best Places to Work (4524)
BIO (40)
Biologics (52)
BIOSECURE Act (10)
Biosimilars (153)
BioSpace Insights (69)
Biotechnology (22)
Bispecific (26)
Bladder cancer (142)
Brain cancer (28)
Breast cancer (432)
Cancer (3396)
Cardiovascular disease (322)
Career advice (574)
Career pathing (33)
CAR-T (161)
CDC (18)
CDMO (101)
Celiac Disease (2)
Cell-line development (1)
Cell therapy (402)
Cervical cancer (22)
Clinical research (29807)
Collaboration (1102)
Commercialization (38)
Company closure (4)
Compensation (373)
Complete response letters (70)
COVID-19 (1020)
CRISPR (45)
CRO (5)
C-suite (684)
Cystic fibrosis (56)
Data (5199)
Decentralized trials (2)
Denatured (14)
Depression (114)
Dermatology (127)
Diabetes (373)
Diagnostics (2595)
Digital health (28)
Diversity (9)
Diversity, equity & inclusion (14)
Drug discovery (192)
Drug pricing (179)
Drug shortages (25)
Duchenne muscular dystrophy (152)
Earnings (36871)
Editorial (49)
Employer branding (10)
Employer resources (64)
ESMO (160)
Events (33893)
Executive appointments (554)
Eye disease (8)
FDA (10782)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (2)
Friedreich's ataxia (10)
Frontotemporal dementia (16)
Funding (731)
Gene editing (102)
Generative AI (48)
Gene therapy (298)
GLP-1 (702)
Government (1390)
Grass and pollen (1)
Guidances (293)
Healthcare (5366)
Hematology (98)
HIV (45)
Huntington's disease (38)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (52)
Immunology and inflammation (238)
Immuno-oncology (97)
Indications (137)
Infectious disease (1213)
Inflammatory bowel disease (141)
Inflation Reduction Act (6)
Influenza (68)
Intellectual property (208)
Interviews (102)
IPO (7055)
IRA (43)
Job creations (1259)
Job search strategy (473)
JPM (39)
Kidney cancer (13)
Kidney disease (64)
Labor market (93)
Layoffs (275)
Leadership (36)
Legal (2398)
Licensing (69)
Liver cancer (46)
Longevity (12)
Lung cancer (457)
Lung diease (13)
Lymphoma (275)
Machine learning (32)
Management (28)
Manufacturing (682)
Marketing (25)
MASH (148)
Medical affairs (4)
Medical device (5084)
Medtech (5190)
Mergers & acquisitions (9063)
Metabolic disorders (1130)
Middle East (1)
mRNA (104)
Multiple sclerosis (140)
Multispecific (4)
NASH (11)
Netherlands (17)
Neurodegenerative disease (245)
Neuropsychiatric disorders (83)
Neuroscience (1871)
Neurotech (1)
NextGen: Class of 2026 (1683)
Non-profit (486)
Now hiring (60)
Obesity (596)
Opinion (184)
Ovarian cancer (125)
Pain (189)
Pancreatic cancer (214)
Parkinson's disease (216)
Partnered (14)
Patents (468)
Patient advocacy (4)
Patient recruitment (347)
Patient selection (38)
Peanut (27)
People (19844)
Peptides (19)
Pharmaceutical (16)
Pharmacy benefit managers (27)
Phase 1 (8424)
Phase 2 (13085)
Phase 3 (11133)
Pipeline (7679)
Policy (218)
Postmarket research (789)
Preclinical (3154)
Press Release (6)
Prostate cancer (191)
Psychedelics (44)
Radiopharmaceuticals (155)
Rare diseases (657)
Real estate (1623)
Recruiting (28)
Regenerative medicine (12)
Regulatory (11375)
Reports (31)
Research institute (482)
Resumes & cover letters (117)
Rett syndrome (32)
RNA editing (16)
RSV (57)
Schizophrenia (145)
Series A (103)
Series B (72)
Service/supplier (3)
Sickle cell disease (38)
Special edition (26)
Spinal muscular atrophy (85)
Sponsored (18)
Startups (1057)
State (1)
Stem cells (2)
Stomach cancer (11)
Substance use disorders (7)
Supply chain (76)
Switzerland (10)
Tariffs (95)
Tax incentives (1)
The Weekly (82)
Vaccines (457)
Venture capital (106)
Weight loss (449)
Wet AMD (3)
Women's health (83)
Women in leadership (1)
Worklife (12)
Date
Today (54)
Last 7 days (389)
Last 30 days (1711)
Last 365 days (14075)
2026 (12953)
2025 (13621)
2024 (15299)
2023 (16982)
2022 (20912)
2021 (20425)
2020 (18361)
2019 (13333)
2018 (10397)
2017 (12651)
2016 (10837)
2015 (12878)
2014 (8669)
2013 (6521)
2012 (6858)
2011 (7290)
2010 (6383)
Location
Africa (254)
Alabama (68)
Alaska (2)
Arizona (93)
Arkansas (5)
Asia (14154)
Australia (1755)
California (6867)
Canada (1364)
China (600)
Colorado (370)
Connecticut (389)
Delaware (252)
Europe (33413)
Florida (1465)
Georgia (243)
Hawaii (2)
Idaho (9)
Illinois (554)
India (89)
Indiana (411)
Iowa (3)
Japan (426)
Kansas (84)
Kentucky (10)
Louisiana (14)
Maine (54)
Maryland (928)
Massachusetts (4874)
Michigan (122)
Minnesota (372)
Mississippi (4)
Missouri (30)
Montana (9)
Nebraska (5)
Nevada (121)
New Hampshire (27)
New Jersey (2724)
New Mexico (19)
New York (1997)
North Carolina (954)
North Dakota (2)
Northern California (3258)
Ohio (238)
Oklahoma (3)
Oregon (11)
Pennsylvania (1527)
Puerto Rico (24)
Rhode Island (16)
South America (319)
South Carolina (68)
Southern California (3035)
Tennessee (88)
Texas (1580)
United States (26606)
Utah (275)
Virginia (229)
Washington D.C. (43)
Washington State (655)
West Virginia (3)
Wisconsin (59)
Wyoming (1)
243,020 Results for "solasia pharma k k".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
GSK plans 1.2K+ layoffs at Belgium sites as $2.5B restructure gains momentum
The layoffs across GSK’s Belgium sites come on the heels of the pharma’s planned shuttering of its German vaccine manufacturing site, which prompted job cuts for about 650 employees.
October 14, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
SonoClear® System 510(k) Submission Accepted for FDA Review
October 21, 2026
·
2 min read
Drug pricing
Drug prices climb past $250K as US patients balk at the pharmacy
Just one-third of patients prescribed new medicines filled them within 30 days, with a new report from the Institute for Clinical and Economic Review and West Health suggesting that cost is the problem.
October 21, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Contrario Medical Receives FDA 510(k) Clearance for Cyperus Sperm Separation Device
November 2, 2026
·
2 min read
Press Releases
Fziomed Announces FDA 510(k) Clearance for Dynavisc® Tendon Protector in the United States
November 18, 2026
·
3 min read
Press Releases
Masimo Receives FDA 510(k) Clearance for smartSedLine™ to Advance Brain Health During Anesthesia
November 18, 2026
·
5 min read
Press Releases
Urolution Medical Receives FDA 510(k) Clearance for OpenFlo® Catheter
October 9, 2026
·
2 min read
Press Releases
Molecular Designs Earns Its First FDA 510(k) Clearance with SimplicityDx™ Panel FluA/FluB/RSV
November 15, 2026
·
3 min read
Press Releases
AIRS Medical Receives FDA 510(k) Clearance for SwiftSight® Body Composition
October 5, 2026
·
5 min read
Press Releases
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
October 6, 2026
·
8 min read
1 of 24,302
Next